CURIS, INC. Adjustments to Additional Paid in Capital, Warrant Issued
CURIS, INC. (CRIS) reported Adjustments to Additional Paid in Capital, Warrant Issued of $4.80 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-03-24
- CURIS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2024 was $4.80M.
- CURIS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2012 was $615.86K.
- CURIS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2010 was $2.18M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|
| 2024-12-31 | $4.80M 10-K · filed 2026-03-24 |
| 2012-12-31 | $615.86K 10-K · filed 2013-03-13 |
| 2010-12-31 | $2.18M 10-K · filed 2013-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |